Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease.
El Fassi
Daniel
D
Nielsen
Claus H
CH
Kjeldsen
Jens
J
Clemmensen
Ole
O
Hegedüs
Laszlo
L
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001402:B-Lymphocytes / Q000187:drug effects*; D003093:Colitis, Ulcerative / Q000139:chemically induced*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D008231:Lymphopenia / Q000139:chemically induced*; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab